Your browser doesn't support javascript.
loading
Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer.
Wang, Nan; Zhao, Qilin; Huang, Yutang; Wen, Chunjie; Li, Yaji; Bao, Meihua; Wu, Lanxiang.
Afiliação
  • Wang N; Institute of Life Sciences, Chongqing Medical University, Chongqing, China. lxwu@cqmu.edu.cn.
  • Zhao Q; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Huang Y; Institute of Life Sciences, Chongqing Medical University, Chongqing, China. lxwu@cqmu.edu.cn.
  • Wen C; Institute of Life Sciences, Chongqing Medical University, Chongqing, China. lxwu@cqmu.edu.cn.
  • Li Y; Institute of Life Sciences, Chongqing Medical University, Chongqing, China. lxwu@cqmu.edu.cn.
  • Bao M; Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, 410219, China.
  • Wu L; Academician Workstation, Changsha Medical University, Changsha, 410219, China.
Mol Omics ; 19(3): 238-251, 2023 03 27.
Article em En | MEDLINE | ID: mdl-36651104
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / RNA Longo não Codificante / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / RNA Longo não Codificante / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article